(UroToday.com) As a portion of the European Society for Medical Oncology (ESMO) Annual Congress, an Educational Session focused on precision management of patients with prostate cancer was held. In this context, Dr. Mark Rubin presented the role of molecular pathology to guide treatment for patients with advanced prostate cancer.